Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 InhibitorsVindhya Udhane, Marja T. Nevalainen, Andrew Erickson et al.|Molecular Cancer Therapeutics|2019Cited by 26
The role of enzalutamide-induced hyperactive Jak2-Stat5 feed-forward signaling loop on enzalutamide-resistant prostate cancer growth and as a therapeutic target for second-line treatment.Vindhya Udhane, Marja T. Nevalainen, Cristina Maranto et al.|Journal of Clinical Oncology|2019Cited by 2